Cerba Lancet Africa Group
Cerba Lancet Africa is the leading network of clinical pathology and biomedical laboratories in Africa, with the ambition to become the leading diagnostic services provider in Africa and world-class standards of pathology services to patients and medical communities across the continent. Cerba Lancet Africa is a joint venture created in 2019 with the French group Cerba HealthCare, a leading international player in medical diagnosis, and Lancet Laboratories, the foremost name in clinical pathology in sub-Saharan Africa.
Through the Joint Venture, Cerba Lancet Africa operates a network of more than 100 ISO-accredited laboratories across 12 African countries: Kenya, Tanzania, Uganda, Rwanda, Botswana, Ghana, Mozambique, Nigeria, Eswatini, Gabon, Zambia, and Zimbabwe.
“Our goal is to provide Africa with the best medical diagnostic solutions at world-class standards to improve the quality of life of communities.”
Tests in the Catalogue
Number of Sites
Average Monthly Number of Tests
Average Monthly Number of Patients
Our Mission
To be the leading force in local medical diagnostics in Africa, while offering the highest standards of pathology and biomedical services to patients and medical communities across the continent.
Our Vision
To provide Africa with the best medical diagnostic solutions at world-class standards to improve the quality of life of communities.
Our Values
Respect
Excellence
Commitment
Equity in Health
Latest News
Pollen allergy: causes and symptoms
Newsletters | 2022-08-11
Respiratory allergies affect many people, especially allergic rhinitis which alone affects about 25% of adults. The symptoms vary and are most often non-specific to the allergy.
Understand Allergies Better
Newsletters | 2022-08-11
Allergy is related to the development of an inappropriate reaction of the body to contact with an allergen. This reaction develops in a context that brings together a set of family and environmental factors. It results in the appearance of a wide variety of symptoms that evolve over the course of a lifetime and can affect several organs.
Our Network
Ghana
- No. labs: 27
- No. of patients: 39 000
- No. of tests performed: 148 500
Kenya
- No. labs: 34
- No. of patients: 32 000
- No. of tests performed: 103 000
Nigeria
- No. labs: 11
- No. of patients: 1 800
- No. of tests performed: 53 000
Mozambique
- No. labs: 2
- No. of patients: 2 000
- No. of tests performed: 7 000
Rwanda
- No. labs: 3
- No. of patients: 2 000
- No. of tests performed: 8 000
Eswatini
- No. labs: 5
- No. of patients: 6 200
- No. of tests performed: 17 300
Tanzania
- No. labs: 10
- No. of patients: 14 000
- No. of tests performed: 75 000
Uganda
- No. labs: 30
- No. of patients: 19 000
- No. of tests performed: 77 000
Zambia
- No. labs: 4
- No. of patients: 4 000
- No. of tests performed: 12 500
Zimbabwe
- No. labs: 23
- No. of patients: 24 000
- No. of tests performed: 78 000
Current Network
- Botswana
- Gabon
- Ghana
- Kenya
- Nigeria
- Mozambique
- Rwanda
- Eswatini
- Tanzania
- Uganda
- Zambia
- Zimbabwe